Cubist Systematic Strategies, LLC Charles River Laboratories International, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.6 Billion
- Q1 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 3,500 shares of CRL stock, worth $484,715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,700
5.41%
Holding current value
$484,715
Previous $683,000
22.99%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$846 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$705 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$593 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$331 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$270 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.04B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...